SANTA MONICA, Calif. – Parallax Health Sciences has acquired QOLPOM, an Arizona-based remote patient monitoring and telehealth technology and services company. “Parallax is excited to enter this growing market with such an innovative company utilizing leading edge technology,” said Parallax CEO J. Michael Redmond in a press release. Parallax has the rights to a line of point-of-care diagnostic tests on a single proprietary platform. Its plans include developing a handheld diagnostic testing system to transition critical tests from the centralized lab directly to the hands of the physician or caregivers, or for home use. “The connectivity between Parallax’s assets, operations and technology with our QOLPOM resources makes for a robust and flexible array of services that consumers will be able to tailor to their personal and loved one’s needs,” said QOLPOM President Nathanial Bradley. “This is an exciting time to be part of the Parallax team.” QOLPOM is an end-to-end provider of remote patient monitoring, telehealth and behavioral modification products and services, with clients in Arizona, California, New York, Oregon and New Jersey.
You are here: / / Parallax enters remote patient monitoring market